Show simple item record

dc.contributor.authorMowlaboccus, S
dc.contributor.authorDaley, DA
dc.contributor.authorBirdsall, J
dc.contributor.authorGottlieb, T
dc.contributor.authorMerlino, J
dc.contributor.authorNimmo, GR
dc.contributor.authorGeorge, N
dc.contributor.authorKorman, T
dc.contributor.authorStreitberg, R
dc.contributor.authorRobson, J
dc.contributor.authorPeachey, G
dc.contributor.authorCollignon, P
dc.contributor.authorBradbury, S
dc.contributor.authorRogers, BA
dc.contributor.authorCoombs, GW
dc.date.accessioned2021-09-24T05:47:57Z
dc.date.available2021-09-24T05:47:57Z
dc.date.issued2021
dc.identifier.issn1198-743X
dc.identifier.doi10.1016/j.cmi.2021.04.029
dc.identifier.urihttp://hdl.handle.net/10072/408355
dc.description.abstractFosfomycin is a broad-spectrum antibiotic that targets UDP-Nacetylglucosamine enolpyruvyl transferase (MurA), an important enzyme in the early stages of peptidoglycan biosynthesis. In Escherichia coli, fosfomycin resistance can occur through the presence of fos genes (typically fosA3) which encode fosfomycininactivating enzymes (FosA, FosC2), or by mutations in proteins important for the uptake of fosfomycin (CyaA, GlpT, PtsI, UhpA, UhpT) or for its action (MurA)
dc.languageeng
dc.publisherElsevier BV
dc.relation.ispartofpagefrom1360
dc.relation.ispartofpageto1361
dc.relation.ispartofissue9
dc.relation.ispartofjournalClinical Microbiology and Infection
dc.relation.ispartofvolume27
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchMedical bacteriology
dc.subject.fieldofresearchcode3202
dc.subject.fieldofresearchcode320701
dc.titleMolecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia (Letter)
dc.typeJournal article
dc.type.descriptionC2 - Articles (Other)
dcterms.bibliographicCitationMowlaboccus, S; Daley, DA; Birdsall, J; Gottlieb, T; Merlino, J; Nimmo, GR; George, N; Korman, T; Streitberg, R; Robson, J; Peachey, G; Collignon, P; Bradbury, S; Rogers, BA; Coombs, GW, Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia (Letter), Clinical Microbiology and Infection, 2021, 27 (9), pp. 1360-1361
dcterms.dateAccepted2021-04-24
dc.date.updated2021-09-23T23:46:03Z
gro.hasfulltextNo Full Text
gro.griffith.authorNimmo, Graeme R.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record